Washington, DC (July 17, 2026) — As the market for unregulated peptide products continues to grow, the American Pharmacists Association (APhA) is urging FDA and the Pharmacy Compounding Advisory Committee (PCAC) to prioritize patient safety, scientific evidence

Washington, DC  (May 22, 2026) — The American Pharmacists Association (APhA) is deeply concerned by the removal of the vice chairs of the U.S. Preventive Services Task Force (USPSTF). For decades, USPSTF has served as a trusted, nonpartisan authority providing rigorous, evidence-based recommendations that guide preventive care and screenings across the health care system. 

WASHINGTON, DC (April 9, 2026) — The American Pharmacists Association (APhA) is pleased to announce that Melissa Somma McGivney, PharmD, FCCP, FAPhA, will join the organization as its inaugural Chief of Professional and Member Experience, effective June 1, 2026.